Table 1.

Spearman Correlation (Rho, P Value) Between Candidate Biomarkers in CLARITY‐TIMI 28

	hsCRP	MPO	PAPP‐A	GDF‐15	NT‐proBNP	MR‐proANP	ST2	Gal‐3	TnT	Copeptin	MR‐proADM
hsCRP	—	0.09	−0.06	0.12	0.31	0.04	0.05	0.19	0.18	−0.11	0.12
MPO	P<0.01	—	0.60	0.11	0.02	−0.16	0.05	0.31	0.09	−0.04	−0.29
PAPPA	P=0.09	P<0.01	—	0.04	−0.04	−0.22	−0.03	0.04	0.02	−0.03	−0.36
GDF‐15	P<0.01	P<0.01	P=0.27	—	0.15	0.04	0.10	0.29	0.13	0.07	−0.03
NT‐proBNP	P<0.01	P=0.55	P=0.21	P<0.01	—	0.34	0.13	0.18	0.54	−0.15	0.26
MR‐proANP	P=0.20	P<0.01	P<0.01	P=0.24	P<0.01	—	0.07	0.15	0.19	0.25	0.67
ST2	P=0.08	P=0.10	P=0.46	P<0.01	P<0.01	P=0.02	—	0.14	0.15	0.07	0.08
Gal‐3	P<0.01	P<0.01	P=0.33	P<0.01	P<0.01	P<0.01	P<0.01	—	0.18	0.12	0.09
TnT	P<0.01	P<0.01	P=0.59	P<0.01	P<0.01	P<0.01	P<0.01	P<0.01	—	−0.27	0.19
Copeptin	P<0.01	P=0.22	P=0.43	P=0.02	P<0.01	P<0.01	P=0.02	P<0.01	P<0.01	—	0.14
MR‐proADM	P<0.01	P<0.01	P<0.01	P=0.27	P<0.01	P<0.01	P=0.01	P<0.01	P<0.01	P<0.01	—

Rho values in upper right and P values in lower left of table. Gal‐3 indicates galectin‐3; GDF‐15, growth‐differentiation factor‐15; hsCRP, high‐sensitivity C‐reactive protein; MPO, myeloperoxidase; MR‐proADM, midregional proadrenomedullin; MR‐proANP, midregional proatrial natriuretic peptide; NT‐proBNP, NT‐pro B‐type natriuretic peptide; PAPP‐A, pregnancy‐associated plasma protein A; ST2, suppression of tumorigenicity 2; TnT, troponin T.